Australia's TGA seeks comment on adopting EU biosimilars guidelines
This article was originally published in SRA
Executive Summary
Australia's Therapeutic Goods Administration is seeking comments on whether or not to adopt two of the European Medicines Agency's overarching biosimilar guidelines as well as eight other EU guidelines covering drugs1.